Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Spirito

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Journal of Cardiology|May 15, 2023
Prognostic value of high-sensitivity C-reactive protein among chronic kidney disease patients undergoing percutaneous coronary interventionDavis Jones, Alessandro Spirito, Samantha Sartori, et al.
Journal of Cardiovascular Translational Research|April 22, 2021
Design and Rationale of the Swiss-Apero Randomized Clinical Trial: Comparison of Amplatzer Amulet vs Watchman Device in Patients Undergoing Left Atrial Appendage ClosureRoberto Galea, Federico De Marco, Adel Aminian, et al.
Journal of Clinical Medicine|November 13, 2021
Age and Sex Specific Prevalence of Clinical and Screen-Detected Atrial Fibrillation in Hospitalized PatientsLaurent Roten, Eleni Goulouti, Anna Lam, et al.
JACC. Advances|June 28, 2024
Sex Differences Among Patients Receiving Edoxaban vs Vitamin K Antagonist for Atrial Fibrillation After TAVRRoxana Mehran, Alessandro Spirito, James Jin, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 10, 2023
Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO-3 randomized trialDaniel Feldman, Davide Cao, Samantha Sartori, et al.
European Heart Journal|October 8, 2020
Validation of high bleeding risk criteria and definition as proposed by the academic research consortium for high bleeding riskNoé Corpataux, Alessandro Spirito, Felice Gragnano, et al.
Journal of the American Heart Association|June 8, 2021
Sex-Based Differences in Bleeding Risk After Percutaneous Coronary Intervention and Implications for the Academic Research Consortium High Bleeding Risk CriteriaAlessandro Spirito, Felice Gragnano, Noé Corpataux, et al.
The American Journal of Cardiology|June 24, 2023
Percutaneous Coronary Intervention in Men, Women, and Minorities With a Previous Coronary Artery Bypass Graft Surgery (from the Pooled PLATINUM Diversity and PROMUS Element Plus Registries)Frans J Beerkens, Davide Cao, Wayne Batchelor, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 9, 2021
Impact of clinical presentation on bleeding risk after percutaneous coronary intervention and implications for the ARC-HBR definitionFelice Gragnano, Alessandro Spirito, Noé Corpataux, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 7, 2022
Perioperative management of P2Y12 inhibitors in patients undergoing cardiac surgery within 1 year of PCIDavide Cao, Julie A Swain, Samantha Sartori, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Journal of Cardiology|May 15, 2023
Prognostic value of high-sensitivity C-reactive protein among chronic kidney disease patients undergoing percutaneous coronary interventionDavis Jones, Alessandro Spirito, Samantha Sartori, et al.
Journal of Cardiovascular Translational Research|April 22, 2021
Design and Rationale of the Swiss-Apero Randomized Clinical Trial: Comparison of Amplatzer Amulet vs Watchman Device in Patients Undergoing Left Atrial Appendage ClosureRoberto Galea, Federico De Marco, Adel Aminian, et al.
Journal of Clinical Medicine|November 13, 2021
Age and Sex Specific Prevalence of Clinical and Screen-Detected Atrial Fibrillation in Hospitalized PatientsLaurent Roten, Eleni Goulouti, Anna Lam, et al.
JACC. Advances|June 28, 2024
Sex Differences Among Patients Receiving Edoxaban vs Vitamin K Antagonist for Atrial Fibrillation After TAVRRoxana Mehran, Alessandro Spirito, James Jin, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 10, 2023
Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO-3 randomized trialDaniel Feldman, Davide Cao, Samantha Sartori, et al.
European Heart Journal|October 8, 2020
Validation of high bleeding risk criteria and definition as proposed by the academic research consortium for high bleeding riskNoé Corpataux, Alessandro Spirito, Felice Gragnano, et al.
Journal of the American Heart Association|June 8, 2021
Sex-Based Differences in Bleeding Risk After Percutaneous Coronary Intervention and Implications for the Academic Research Consortium High Bleeding Risk CriteriaAlessandro Spirito, Felice Gragnano, Noé Corpataux, et al.
The American Journal of Cardiology|June 24, 2023
Percutaneous Coronary Intervention in Men, Women, and Minorities With a Previous Coronary Artery Bypass Graft Surgery (from the Pooled PLATINUM Diversity and PROMUS Element Plus Registries)Frans J Beerkens, Davide Cao, Wayne Batchelor, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 9, 2021
Impact of clinical presentation on bleeding risk after percutaneous coronary intervention and implications for the ARC-HBR definitionFelice Gragnano, Alessandro Spirito, Noé Corpataux, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 7, 2022
Perioperative management of P2Y12 inhibitors in patients undergoing cardiac surgery within 1 year of PCIDavide Cao, Julie A Swain, Samantha Sartori, et al.
Pageof 8